Vaayssier M, Favatier F, Pinot F, Bachelet M and Polla BS (1998) Tobacco smoke induces coordinate activation of NSF and inhibition of NFkB in human monocytes: effects on TNFa release. Biochemical and Biophysical Research Communications 252 249-256<\/p>\n
Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M, Frati L, Gulino A and Screpanti I (2006) Notch3 and pre-TCR interaction unveils distinct NF-kB pathways in T-cell development and leukemia.\u00a0EMBO Journal 25 1000-1008<\/p>\n
Vafeiadou K, Vauzour D and Spencer JP (2007) Neuroinflammation and its modulation by flavonoids.\u00a0Endocrine,\u00a0Metabolic & Immune Disorder Drug Targets\u00a07 211-224<\/p>\n
Vaillancourt F, Morquette B, Shi Q, Fahmi H, Lavigne P, Di Battista JA, Fernandes JC and Benderdour M (2007) Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2\/CREB-1 transactivation and concomitant inhibition\u00a0of NF-kB signaling cascade.\u00a0Journal of Cellular Biochemistry\u00a0100 1217-1231<\/p>\n
Vainer GW, Pikarsky E and Ben-Neriah Y (2008) Contradictory functions of NF-kB in liver physiology and cancer. Cancer Letters in press<\/p>\n
Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R and Novack DV (2008) RelA\/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. Journal of Clinical Investigation 118 2088-2097<\/p>\n
Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, Sammut B, O’Neal J, Zou W, Weilbaecher KN, Faccio R and Novack DV (2008)\u00a0RelB is the NF-kB subunit downstream of NIK responsible for osteoclast differentiation. Proceedings of the National Academy of Sciences USA 105 3897-3902<\/p>\n
Vaisman N, Haenen GR, Zaruk Y, Verduyn C, Bindels JG, Verlaan S and Meijer EP (2006) Enteral feeding enriched with carotenoids normalizes the carotenoid status and reduces oxidative stress in long-term enterally fed patients.Clinical\u00a0Nutrition 25 897-905<\/p>\n
Vaititis GM and Wagner Jr DH (2008) High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLos ONE 3 e2076<\/p>\n
Vakkila J, Demarco RA and Lotze MT (2004) Imaging analysis of STAT1 and NF-kB translocation in dendritic cells at the single cell level. Journal of Immunological Methods 294 123-134<\/p>\n
Vakkila J, Demarco RA and Lotze MT (2004)Coordinate NF-kB and STAT1 activation promotes development of myeloid type 1 dendritic cells. Scandinavian Journal of Immunology 67 260-269<\/p>\n
Valacchi G, Pagnin E, Phung A, Nardini M, Schock BC, Cross CE and Van Der Vliet A (2005) Inhibition of NFkB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxidant and Redox Signaling 7 25-31<\/p>\n
Valacchi G, Rimbach G, Saliou C, Weber SU and Packer L (2001) Effect of benzoylperoxide on antioxidant status, NF-kB activity and interleukin-1alpha gene expression in human keratinocytes. Toxicology 165 225-234<\/p>\n
Valacchi G, Pagnin E, Corbacho AM, Olano E, Davis PA, Packer L and Cross CE (2004) In vivo ozone exposure induces antioxidant\/stress-related responses in murine lung and skin. Free Radical Biology and Medicine 36 673-681<\/p>\n
Valachovicova T, Slivova V, Bergman H, Shuherk J and Sliva D (2004) Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kB\/AP-1-dependent and -independent pathways. International Journal of Oncology 25 1389-1395<\/p>\n
Valanciute A, Le Gouvello S, Solhonne B, Pawlak A, Grimbert P, Lyonnet L, Hue S, Lang P, Remy P, Salomon R, Bensman A, Guellaen G and Sahali D (2004) NF-kB p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. Journal of Immunology 172 688-698<\/p>\n
Valarcher JF and Taylor G (2007) Bovine respiratory syncytial virus infection. Veterinary Research\u00a038 153-180<\/p>\n
Valdes JA, Hidalgo J, Galaz JL, Puentes N, Silva J, Jaimovich E and Carrasco MA (2007) NF-kB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals. American Journal of Physiology: Cell Physiology\u00a0292 C1960-C1970<\/p>\n
Valdez KE and Turzillo AM (2005) Regulation of nuclear factor-kB (NF-kB) activity and apoptosis by estradiol in bovine granulosa cells. Molecular and Cellular Endocrinology\u00a0243 66-73<\/p>\n
Valdiva C, Marquez N, Eriksson J, Vilaseca A, Munoz E and Sterner O (2008) Bioactive alkenylphenols from Piper obliquum. Biorganic Medicinal Chemistry 16 4120-4126<\/p>\n
Vale T, Ngo TT, White MA and Lipsky PE (2001) Raf-induced transformation requires an interleukin 1 autocrine loop. Cancer Research 61 602-607<\/p>\n
Valen G (2004) NFkB in myocardial inflammation. Cardiovascular Journal of South Africa 15 S6<\/p>\n
Valen G, Paulsson G and Vaage J (2001) Induction of inflammatory mediators during reperfusion of the human heart. Annals of Thoracic Surgery 71 226-232<\/p>\n
Valen G, Yan ZQ and Hansson GK (2001) Nuclear factor kB and the heart. Journal of the American College of Cardiology 38 307-314<\/p>\n
Valenca SS, Castro P, Pimenta WA, Lanzetti M, Silva SV, Barja-Fidalgo C, VLG Koatz and Porto LC (2006) Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung.
\nInternational\u00a0Journal of Experimental Pathology\u00a087 373-381<\/p>\n
Valencia C, Cornejo P, Romanque P, Tapia G, Varela P, Videla LA and Fernandez V (2004) Effects of acute lindane intoxication and thyroid hormone administration in relation to nuclear factor-kB activation, tumor necrosis factor-a expression, and Kupffer cell function in the rat. Toxicology Letters 148 21-28<\/p>\n
Valente P, Arzani D, Cesario A, Margaritora S, Carbone E and Russo P (2003) TNF increases camptothecin-induced apoptosis by inhibition of NF-kB. European Journal of Cancer 39 1468-1477<\/p>\n
Valentinis B, Capobianco A, Esposito F, Bianchi A, Rovere-Zuerini P, Manfredi AA and Traversari C (2008) Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity. Journal of Leukocyte Biology in press<\/p>\n
Valera FC, Queiroz R, Scrideli C, Tone LG and Anselmo-Lima WT (2008) Expression of transcription factors NF-kB and AP-1 in nasal polyposis. Clinical and Experimental Allergy 38 579-585<\/p>\n
Valeri CR, Ragno G and Veech RL (2006) Effects of the resuscitation fluid and the hemoglobin based oxygen carrier (HBOC) excipient on the toxicity of the HBOC: Ringer’s D,L-lactate, Ringer’s L-lactate, and Ringer’s ketone solutions.
\nArtificial\u00a0Cells, Blood Substitutes, and Immobilization Biotechnology\u00a034\u00a0601-606<\/p>\n
Valerio A, Boroni F, Benarese M, Sarnico L, Ghisi V, Bresciani LG, Ferrario M, Borsani G, Spano P and PIzzi M (2006) NF-kB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production.\u00a0EuropeanJournal of Neuroscience\u00a023 1711-1720<\/p>\n
Valerio LG and Gonzales GF (2005) Toxicological aspects of the South American herbs Cat’s Claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis.\u00a0Toxicology Reviews\u00a024 11-35<\/p>\n
Valero R, Baron ML, Guerin S, Beliard S, Lelouard H, Kahn-Perles B, Vialettes B, Nguyen C, Imbert J and Naquet P (2002) A defective NF-kB\/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells. Journal of Immunology 169 185-192<\/p>\n
Vales LD and Friedl EM (2002) Binding of C\/EBP and RBP (CBF1) to overlapping sites regulates IL-6 gene expression. Journal of Biological Chemistry 277 42438-24446<\/p>\n
Valko M, Morris H and Cronin MT (2005) Metals, toxicity and oxidative stress.Current Medicinal Chemistry\u00a012 1161-1208<\/p>\n
Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer.\u00a0Chemico-BiologicalInteractions\u00a0160 1-40<\/p>\n
Vallabhapurapu S and Karin M (2009) Regulation and function of NF-kB transcription factors in the immune system. Annual Reviews of Immunology 27 693-733<\/p>\n
Vallabhapurapu S, Ryseck RP, Malewicz M, Weih DS and Weih F (2001) Inhibition of NF-kB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld\/gld mice. European Journal of Immunology 31 2612-2622<\/p>\n
Vallat L, Magdelenat H, Merle-Beral H, Masdehors P, Potocki De Montalk G, Davi F, Kruhoffer M, Sabatier L, Orntoft TF and Delic J (2003) The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays. Blood 101 4598-4606<\/p>\n
Vallat-Decouvelaere AV, Bretel MA, Vassias I, Laplanche JL, Polivka M, Wassef M, Brunet M, Thiebaut JB, Gosselin B, Morinet F and Mikol J (2002) High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin’s brain lymphomas. Neuropathology and Applied Neurobiology 28 471-479 <\/strong><\/p>\n <\/strong><\/p>\n Vallee I, Tait SW and Powell PP (2001) African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis. Journal of Virology 75 10372-10382<\/p>\n Vallee S, Fouchier F, Bremond P, Briand C, Marvaldi J and Champion S (2003) Insulin-like growth factor-1 downregulates nuclear factor kB activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor alpha. Biochemical and Biophysical Research Communications 305 831-839<\/p>\n Vallee S, Laforest S, Fouchier F, Montero MP, Penel C and Champion S (2004) Cytokine-induced upregulation of NF-kB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta. Experimental Cell Research 297 165-185<\/p>\n Valles SL, Blanco AM, Azorin I, Guasch R, Pascual M, Gomez-Lechon MJ, Renau-Piqueras J and Guerri C (2003) Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes. Alcohol Clin Exp Res 27 1979-1986<\/p>\n Valles SL, Blanco AM, Pascual M and Guerri C (2004) Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathology 14 365-371<\/p>\n Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross Jr J, Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D and Lang F (2006) SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Journal of\u00a0Molecular\u00a0Medicine\u00a084 396-404<\/p>\n Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY and Fest T (2005) c-Flip protein expression in Burkitt’s lymphomas is associated with a poor clinical outcome. British Journal of Haematology 128 767-773<\/p>\n Van Acker GJ, Weiss E, Steer ML and Perides G (2007) Cause-effect relationships between symogen activation and other early events in secretagogue-induced acute pancreatitis.\u00a0\u00a0American\u00a0Journal of\u00a0Physiology:\u00a0Gastrointestinal and\u00a0Liver Physiology\u00a0292 G1738-G1746<\/p>\n Van Antwerp DJ and Verma IM (1996) Signal-induced degradation of IkBa: association with NF-kB and the PEST sequence in IkBa are not required. Molecular and Cellular Biology 16 6037-6045<\/p>\n Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma I (1996) Suppression of TNF-a-induced apoptosis by NF-kB. Science 274 787-789<\/p>\n Van Antwerp DJ, Martin SJ, Verma IM and Green DR (1998) Inhibition of TNF-induced apoptosis by NF-kB. Trends in Cell Biology 8 107-111<\/p>\n van Asbeck BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS and Marx JJ (2001) Anti-HIV effect of iron chelators: different mechanisms involved. Journal of Clinical Virology 20 141-147<\/p>\n van Aubel RA, Keestra AM, Krooshoop DJ, van Eden W and van Putten JP (2007) Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.\u00a0Molecular\u00a0Immunology\u00a044 3702-3714<\/p>\n Van Bezooijen RL, Papapoulos SE and Lowik CW (2001) Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kB and receptor activator of nuclear factor kB (RANK)\/RANK ligand signaling? Bone 28 378-386<\/p>\n van de Sluis B, Muller P, Duran K, Chen A, Groot AJ, Klomp LW, Liu PP and WIjmenga C (2007) Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice.\u00a0Molecular and\u00a0CellularBiology 27 41442-4156<\/p>\n Van De Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF and Van Der Saag PT (2004) Estrogen receptor (ER)-mediated transcriptional regulation of the human Corticotropin-Releasing Hormone-Binding Protein promoter: differential effects of ERa and ERb. Molecular Endocrinology 18 2908-2923<\/p>\n Van De Walle J, Romier B, Larondelle Y and Schneider YJ (2008)\u00a0Influence of deoxynivalenol on NF-kB activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicology Letters 177 205-214<\/p>\n Van De Woouwer M, Plaisance S, De Vriese A, Waelkens D, Collen D, Persson J, Daha MR and Conway EM (2006) The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.\u00a0Journal of\u00a0Thrombosis and Haemostosis\u00a04 1813-1824<\/p>\n Van Den Berg A, Kroesen BJ, Kooistra K, De Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E and Poppema S (2003) High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes and Cancer 37 20-28<\/p>\n van den Berg R, Haenen GR, van den Berg H and Bast A (2001) Transcription factor NF-kB as a potential biomarker for oxidative stress. British Journal of Nutrition 86 Suppl 1 S121-S127<\/p>\n van den Brandt J, Kwon SH, McPherson KG, Petrovic S, Zettle A, Muller-Hermelink HK and Reichardt HM (2006) Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats. van Den Brink GR, ten Kate FJ, Ponsioen CY, Rive MM, Tytgat GN, van Deventer SJ and Peppelenbosch MP (2000) Expression and activation of NF-kB in the antrum of the human stomach. Journal of Immunology 164 3353-3359<\/p>\n van den Heuvel MJ, Copeland KF, Cates EC, Jefferson BJ and Jacobs RM (2007) Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkB element in the long terminal repeat.\u00a0Canadian\u00a0Journal of Veterinary Research\u00a071 119-128<\/p>\n van den Tweel ER, Kavelaars A, Lombardi MS, Groenendaal F, May M, Heijnen CJ and van Bel F (2006) Selective inhibition of nuclear factor-kB activation after hypoxia\/ischemia in neonatal rats is not neuroprotective.\u00a0Pediatric\u00a0Research\u00a059 232-236<\/p>\n van der Crabben SN, Allick G, Ackermans MT, Endert E, Romijn JA and Sauerwein HP (2008) Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. Journal of Clinical Endocrinology and Metabolism 93 638-641<\/p>\n Van Der Hoeven JA, Moshage H, Schuurs T, Nijboer M, Van Schilfgaarde R and Ploeg RJ (2003) Brain death induces apoptosis in donor liver of the rat. Transplantation 76 1150-1154<\/p>\n Van Der Paardt M, Crusius JB, De Koning MH, Murillo LS, Van De Stadt RJ, Dijkmans BA, Pena AS and Van Der Horst-Bruinsma IE (2003) CARD15 gene mutations are not associated with ankylosing spondylitis. Genes and Immunity 4 77-78<\/p>\n Van Der Woude CJ, Kleibeuker JH, Jansen PL and Moshage H (2004) Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 9 123-130<\/p>\n van Duist MM, Albrecht M, Podswiadek M, Giachino D, Lengauer T, Punzi L and De Marchi M (2005) A new CARD15 mutation in Blau syndrome. European Journal of Human Genetics\u00a013 742-747<\/p>\n Van Epps HL (2006) Finding NEMO mutations. Journal of Experimental Medicine 203 1620<\/p>\n van Erk MJ, Blom WA, van Ommen B and Hendriks HF (2006) High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells.\u00a0American\u00a0Journal of Clinical Nutrition\u00a084 1233-1241<\/p>\n van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf A, Bouillon R, Roep BO, Badenhoop K and Mathieu C (2007) The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system.\u00a0European\u00a0Journal of Immunology\u00a037 395-405<\/p>\n van Eyndhoven WG, Gamper CJ, Cho E, Mackus WJ and Lederman S (1999) TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation. Molecular Immunology 36 647-658<\/p>\n Van Heel DA, McGovern DP and Jewell DP (2001) Crohn’s disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357 1902-1904<\/p>\n Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP and Kwiatkowski D (2002) Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Human Molecular Genetics 11 1281-1289<\/p>\n Van Hogerlinden M, Auer G and Toftgard R (2002) Inhibition of Rel\/Nuclear factor-kB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53- independent tumor development. Oncogene 21 4969-4977<\/p>\n van Hogerlinden M, Rozell BL, \u00c4hrlund-Richter L and Toftg\u00e5rd R (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel\/nuclear factor-kB signaling. Cancer Research 59 3299-3303<\/p>\n Van Hogerlinden M, Rozell BL, Toftgard R and Sundberg JP (2004) Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-kB signaling. Journal of Investigative Dermatology 123 101-108<\/p>\n Van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zyberk C, Vervoordeldonk MJ and Tak PP (2004) Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Research Therapy 6 R239-R249<\/p>\n Van Huffel S, Delaei F, Heyninck K, De Valck D and Beyaert R (2001) Identification of a novel A20-binding inhibitor of nuclear factor-kB activation termed ABIN-2. Journal of Biological Chemistry 276 30216-30223<\/p>\n Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2006)\u00a0Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.\u00a0Cancer Research\u00a066\u00a05744-5756<\/p>\n Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2006)\u00a0Nuclear factor-kB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kB DNA-binding.\u00a0Clinical\u00a0Cancer Research\u00a012\u00a03249-3256<\/p>\n Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2007)\u00a0NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and\/or ErbB2 overexpression and MAPK hyperactivation.\u00a0British\u00a0Journal of\u00a0Cancer\u00a097 659-669<\/p>\n van Leeuwen HJ, van der Bruggen T, van Asbeck BS and Boereboom FT (2001) Effect of corticosteroids on nuclear factor-kB activation and hemodynamics in late septic shock. Critical Care Medicine 29 1074-1077<\/p>\n Van Lint C, Quivy V, Demonte D, Chariot A, Vanhulle C, de Walque S, Gaudray G, Veithen E, Bours V, Piette J and Burny A (2004) Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies. Bull Mem Acad R Med Belg 159 176-189<\/p>\n van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinz MR and Pasparakis M (2006) Inhibition of transcription factor NF-kB in the central nervous system ameliorates autoimmune encephalomyelitis in mice.\u00a0Nature\u00a0Immunology 7 954-961<\/p>\n Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK and Baltimore D (1999) Uncoupling IL-2 signals that regulate T cell proliferation, survival and Fas-mediated activation-induced cell death. Immunity 11 281-288<\/p>\n Van PL, Yim KW, Jin DY, Dapolito G, Kurimasa A and Jeang KT (2001) Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53. Journal of Virology 75 396-407<\/p>\n Van Den Brande JM, Braat H, Van Den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, Van Montfrans C, Hommes DW, Peppelenbosch MP and Van Deventer SJ (2003) Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease. Gastroenterology 124 1774-1785<\/p>\n Van den Oord JJ, Sarasin A, Winnepenninckx V and Spatz A (2007) Expression profiling of melanoma cell lines: in search of a progression-related molecular signature. Future Oncology 3 609-611<\/p>\n van Galen JC, Muris JJ, Giroth CP, Vos W, Ossenkoppele GJ, Meijer CJ and Oudejans JJ (2008) Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas. Histopathology\u00a052 578-584<\/p>\n Van Laere S, Van der Auwere I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, Van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2005) Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.\u00a0Breast Cancer Research Treatment\u00a093 237-246<\/p>\n Van Luu C, Van Chau M Lee JJ and Jung SH (2006) Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kB activation.\u00a0Archives of\u00a0Pharmacal\u00a0Research\u00a029\u00a0840-844<\/p>\n van Oers NS and Chen ZJ (2005) Cell biology. Kinasing and clipping down the NF-kB trail. Science 308 65-66<\/p>\n Van Puijenbroek AA, Wissink S, van der Saag PT and Peppelenbosch MP (1999) Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kB activation. Cytokine 11 104-110<\/p>\n Van Putten V, Refaat Z, Dessev C, Blaine S, Wick M, Butterfield L, Han SY, Heasley LE and Nemenoff RA (2001) Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. Journal of Biological Chemistry 276 1226-1232<\/p>\n van Uden P, Kenneth NS and Rocha S (2008) Regulation of hypoxia inducible factor-1alpha by NF-kB. Biochemical Journal in press<\/p>\n van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML and Tiganis T (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nature Immunology 6 253-260<\/p>\n Van Waes C (2007) Nuclear factor-kB in development, prevention, and therapy of cancer.\u00a0Clinical\u00a0Cancer Research\u00a013 1076-1082<\/p>\n Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy SF, Morris JC, Mitchell JB, Camphausen K, Gius D, Adams J, Sausville EA and Conley BA (2005) Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.\u00a0Int J Radiat Oncol Biol Phys 63 1400-1412<\/p>\n Van Wijngaarden J, van Beek E, van Rossum G, van der Bent C, Hoekman K, van der Pluijm G, van der Pol MA, Broxterman HJ, van Hinsbergh VW and Lowik CW (2006) Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kB-mediated increase of intracellular doxorubicin accumulation. European Journal of Cancer 43 433-442<\/p>\n Vancurova I, Bellani P and Davidson D (2001) Activation of nuclear factor-kB and its suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus adult. Pediatric Research 49 257-262<\/p>\n Vancurova I, Wu R, Miskolci V and Sun Shishinn (2002) Increased p50\/p50 NF-kB activation in human pappilomavirus type-6- or type-11-induced laryngeal papilloma tissue. Journal of Virology 76 1533-1536<\/p>\n Vanden Berghe T, Kalai M, Denecker G, Meeus A, Saelens X and Vandenabeele P (2005) Necrosis is associated with IL-6 production but apoptosis is not. Cell Signaling in press<\/p>\n Vanden Berghe T, Kalai M, Van Loo G, Declercq W and Vandenabeele P (2003) Disruption of HSP90 function reverts TNF-induced necrosis to apoptosis. Journal of Biological Chemistry 278 5622-5629 Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu N, Boone E and Haegeman G (2006) Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kB gene expression by soy isoflavones does not require estrogenic activity.\u00a0Cancer Research\u00a066 4852-4862<\/p>\n Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M and Haegeman G (1999) Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kB-dependent mechanism. Molecular Pharmacology 56 797-806<\/p>\n Vanden Berghe W, Ndlovu MN, Hoya-Arias R, Dijsselbloem N, Gerlo S and Haegeman G (2006) Keeping up NF-kB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochemical Pharmacology in press<\/p>\n Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W and Haegeman G (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kB p65 transactivation mediated by tumor necrosis factor. Journal of Biological Chemistry 273 3285-3290<\/p>\n Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B and Haegeman G (2003) A paradigm for gene regulation: inflammation, NF-kB and PPAR. Adv Exp Med Biol 544 181-196<\/p>\n Vandenberghe I, Creancier L, Vispe S, Annereau JP, Barret JM, Pouny I, Samson A, Aussagues Y, Massiot G, Ausseil F, Bailly C and Kruczynski A (2008) Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis. Biochemical Pharmacology in press<\/p>\n Vandenbroeck K, Alloza I, Gadina M and Matthys P (2004) Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J Pharm Pharmacol 56 145-160<\/p>\n Vandergeeten C, Quivy V, Moutschen M, Van Lint C, Piette J and Legrand-Poels S (2007) HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha+TSA.\u00a0BiochemicalPharmacology in press<\/p>\n Vandermeeren M, Janssens S, Wouters H, Borghmans I, Borgers M, Beyaert R and Geysen J (2001) Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kB1, but not RelA in normal human dermal fibroblast cells. Journal of Investigative Dermatology 116 124-130<\/p>\n Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, Lemoine J and Hondermarck H (2005) The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kB activation induced via interaction between Akt and IkB kinase-b in breast cancer cells. Oncogene 24 5482-5491<\/p>\n Vandermoere F, El Yazidi-Belkoura I, Demont Y, Slomianny C, Antol J, Lemoine J and Hondermarck H (2006)\u00a0Proteomic exploration reveals that actin is a signaling target of the kinase akt.\u00a0Molecular &\u00a0Cellular\u00a0Proteomics\u00a0in press<\/p>\n Vanderpool C, Yan F and Polk DB (2008) Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflammatory Bowel Disease in press<\/p>\n Vandoros GP, Konstantinopoulos PA, Sotiropoulou-Bonikou G, Kominea A, Papchristou GI, Karamouzis MV, Gkermpesi M, Varakis I and Papavassiliou AG (2005) PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas.\u00a0Journal of Cancer Research and Clinical Oncology\u00a08 1-9<\/p>\n Vandromme M, Gauthier-Rouvi\u00e8re C, Lamb N and Fernandez A (1996) Regulation of transcription factor localization: fine-tuning of gene expression. Trends in Biochemical Sciences 21 59-64<\/p>\n Vangasseri DP, Cui Z, Chen W, Hokey DA, Falo LD and Huang L (2006) Immunostimulation of dendritic cells by cationic liposomes.\u00a0Molecular Membrane Biology\u00a023 385-395<\/p>\n Vanlandschoot P, Roobrouck A, Van Houtte F and Leroux-Roels G (2002) Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1\/2 and JNK-1\/2 in monocytes. Biochemical and Biophysical Research Communications 297 486-491<\/p>\n Vanni C, Ottaviano C, Guo F, Puppo M, Varesio L, Zheng Y and Eva A (2005) Constitutively active Cdc42 mutant confers growth disadvantage in cell transformation. Cell Cycle 4\u00a01675-1682<\/p>\n Vannini N, Lorusso G, Cammarota R, Barberis M, Noonan DM, SPorn MB and Albini A (2007) The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Molecular Cancer Therapeutics in press<\/p>\n Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E and Romeo G (2005) TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-beta in cervical carcinoma cells. Oncogene 24 2536-2546<\/p>\n Van’t Hof RJ, Idris AI, Ridge SA, Dunford J, Greig IR and Ralston SH (2004) Identification of biphenylcarboxylic Acid derivatives as a novel class of bone resorption inhibitors. Van’t Land B, Blijlevens NM, Marteijn J, Timal S, Donnelly JP, De Witte TJ and M’Rabet L (2003) Role of curcumin and the inhibition of NF-kB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 18 276-284<\/p>\n van’t Veer LJ, Beijersberen RL and Bernards R (1993) N-myc suppresses major histocompatibility complex Class I gene expression through down-regulation of the p50 subunit of NF-kB. EMBO Journal 12 195-200<\/p>\n Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS and Pandol SJ (2001) Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiology 280 G1197-G1208<\/p>\n Varela LM, Stangle-Castor NC, Shoemaker SF, Shea-Eaton WK and Ip MM (2001) TNFalpha induces NFkB\/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. Journal of Cellular Physiology 188 120-131<\/p>\n Varfolomeev EE and Ashkenazi A (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116 491-497<\/p>\n Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM and Vucic D (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kB activation, and TNFa-dependent apoptosis. Cell 131 669-681<\/p>\n Varfolomeev E and Vucic D (2008) (Un)expected roles of c-IAPs in apoptotic and NFkB signaling pathways. Cell Cycle 7 in press<\/p>\n Varfolomeev E, Wayson SM, Dixit VM, Fiarbrother WJ and Vucic D (2006) The inhibitor of apoptosis protein fusion c-IAP2\/MALT1 stimulates NF-kB activation independently of TRAF1 and TRAF2. Journal of\u00a0Biological\u00a0Chemistry 281 29022-29029<\/p>\n Varga AE, Leonardos L, Jackson P, Marreiros A and Cowled PA (2004) Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma. Neoplasia 6 128-135<\/p>\n Varga Z (2008) Cardioprotective role of omega-3 polyunsaturated fatty acids [Article in Hungarian]. Orv Hetil 149 627-637<\/p>\n Varghese J, Chattopadhaya S and Sarin A (2001) Inhibition of p38 kinase reveals a TNF-a-mediated, caspase- dependent, apoptotic death pathway in a human myelomonocyte cell line. Journal of Immunology 166 6570-6577<\/p>\n Varin A, Decrion AZ, Sabbah E, Quivy V, Sire J, Van Lint C, Roques BP, Aggarwal BB and Herbein G (2005) Synthetic Vpr protein activates AP-1, c-Jun N-terminal kinase and NF-kB, and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. Journal of Biological Chemistry 280 42557-42567<\/p>\n Varin A, Manna SK, Quivy V, Decrion AZ, Van Lint C, Herbein G and Aggarwal BB (2003) Exogenous Nef protein activates NF-kB, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. Journal of Biological Chemistry 278 2219-2227<\/p>\n Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE and Singh RK (2002) Monocyte\/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 16 471-477<\/p>\n Varon C, Duriez A, Lehours P, Menard A, Laye S, Zerbib F, Megraud F and Laharie D (2008) Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut in press<\/p>\n Varro A, Noble PJ, Pritchard DM, Kennedy S, Hart CA, Dimaline R and Dockray GJ (2004) Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kB and RhoA: implications for invasion and apoptosis. Cancer Research 64 1695-702<\/p>\n Varsani H, Patel A, Van Kooyk Y, Woo P and Wedderburn LR (2003) Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kB (RANK). Rheumatology 42 583-590<\/p>\n Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH and Koistinaho J (2003) Aspirin inhibits p44\/42 mitogen-activated protein kinase and is protective against hypoxia\/reoxygenation neuronal damage. Stroke 34 752-757<\/p>\n Vartiainen N, Keksa-Goldsteine V, Goldsteins G and Koistinaho J (2002) Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia\/reoxygenation damage in culture. Journal of Neurochemistry 82 329-335<\/p>\n Varley CL, Armitage S, Hassanshahiraviz G and Dickson AJ (2003) Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes. Cytokine 23 64-75<\/p>\n Vasarhelyi B, Cseh A, Kocsis I, Treszl A, Gyorffy B and Rigo Jr J (2006) Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis.Molecular Human Reproduction 12 31-34<\/p>\n Vaschetto R, Grinstein J, Del Sorbo L, Khine AA, Voglis S, Tullis E, Slutsky AS and Zhang H (2007) Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes. Journal of\u00a0Leukocyte\u00a0Biology in press<\/p>\n Vasilaki A, McArdle F, Iwanejko LM and McArdle A (2006) Adaptive responses of mouse skeletal muscle to contractile activity: The effect of age.\u00a0Mechanisms ofAgeing and Development in press<\/p>\n Vashisht Gopal YN, Arora TS and Van Dyke MW (2005) Tumour necrosis factor-a depletes histone deacetylase 1 protein through IKK2.\u00a0EMBO Reports 7 291-296<\/p>\n Vasilev N, Momekov G, Zaharieva M, Konstantinov S, Bremner P, Heinrich M and Ionkova I (2005) Cytotoxic activity of a podophyllotoxin-like lignan from Linum tauricum Willd.\u00a0Neoplasma\u00a052 425-429<\/p>\n Vasilevskaya IA and O’Dwyer PJ (2005) 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines. Biochemical Pharmacology 70 580-589<\/p>\n Vaskivuo T, Ottander U, Oduwole O, Isomaa V, Vihko P, Olofsson J and Tapanainen J (2002) Role of apoptosis, apoptosis-related factors and 17beta-hydroxysteroid dehydrogenases in human corpus luteum regression. Molecular and Cellular Endocrinology 194 191<\/p>\n Vaskivuo TE, Stenback F and Tapanainen JS (2002) Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kB in human endometrial hyperplasia and carcinoma. Cancer 95 1463-1471<\/p>\n Vassalli G, Fleury S, Li J, Goy JJ, Kappenberger L and von Segesser LK (2003) Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection. European Journal of Cardiothoracic Surgery 24 794-806<\/p>\n Vasseur S, Folch-Puy E, Hlouschek V, Garcia S, Fiedler F, Lerch M, Dagorn JC, Closa D and Iovanna JL (2003) p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein PAP I. Journal of Biological Chemistry 279 7199-7207<\/p>\n Vasto S, Mocchegiani E, Candore G, Listi F, Colonna-Romano G, Lio D, Malavolta M, Giacconi R, Cipriano C and Caruso C (2006) Inflammation, genes and zinc in ageing and age-related diseases.\u00a0Biogerontology\u00a07 315-327<\/p>\n Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listi F, Nuzzo D, Ditta V, Candore G and Caruso C (2007) Zinc and inflammatory\/immune response in aging.Annals of the\u00a0New York Academy of Sciences\u00a01100 111-122<\/p>\n Vasudevan KM, Gurumurthy S and Rangnekar VM (2004) Suppression of PTEN expression by NF-kB prevents apoptosis. Molecular and Cellular Biology 24 1007-1021<\/p>\n Vatsyayan J, Qing G, Xiao G and Hu J (2008) SUMO1 modification of NF-kB2\/p100 is essential for stimuli-induced p100 phosphorylation and processing. EMBO Reports in press<\/p>\n Vavricka SR, Musch MW, Chang JE, Nakagawa Y, Phanvijhitsiri K, Waypa TS, Merlin D, Schneewind O and Chang EB (2004) hPepT1 transports muramyl dipeptide, activating NF-kB and stimulating IL-8 secretion in human colonic Caco2\/bbe cells. Gastroenterology 127 1401-1409<\/p>\n Vayalil PK and Katiyar SK (2004) Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kB in human prostate carcinoma DU-145 cells. Prostate 59 33-42<\/p>\n Vayalil PK, Mittal A and Katiyar SK (2004) Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells which is associated with the inhibition of activation of MAPK and NFkB. Carcinogenesis\u00a025 987-995<\/p>\n Vazquez-Padron RI, Pham SM, Pang M, Li S, Ai;touche A (2004) Molecular dissection of mouse soluble guanylyl cyclase alpha(1) promoter. Biochemical and Biophysical Research Communications 314 208-214<\/p>\n Veal N, Hsieh CL, Xiong S, Mato JM, Lu S and Tsukamoto H (2004) Inhibition of lipopolysaccharide-stimulated TNF{alpha} promoter activity by S-adenosylmethionine and 5′-methylthioadenosine. American Journal of Physiology: Gastrointestinal and Liver Physiology 287 G352-G362<\/p>\n Veber D, Mutti E, Tacchini L, Gammella E, Tredici G and Scalabrino G (2008) Indirect down-regulation of nuclear NF-kB levels by cobalamin in the spinal cord and liver of the rat. Journal of Neuroscience in press<\/p>\n Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S and Julkunen I (2005) TNF-a and IFN-a enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345 96-104<\/p>\n Vega A, Chacon P, Alba G, El Bekay R, Martin-Nieto J and Sobrino F (2006) Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils.\u00a0Journal of\u00a0Leukocyte\u00a0Biology 80 152-163<\/p>\n Vega D, Maalouf NM and Sakhaee K (2007) The role of RANK\/RANKL\/OPG: clinical implications.\u00a0Journal of\u00a0Clinical\u00a0Endocrinology and\u00a0Metabolism in press<\/p>\n Vega F and Medeiros LJ (2001) Marginal-zone B-cell lymphoma of extranodal mucosa-associated lymphoid tissue type: molecular genetics provides new insights into pathogenesis. Adv Anat Pathol 8 313-326<\/p>\n Vega LD, Munoz E, Calzado MA, Lieb K, Candelario-Jalil E, Gschaidmeir H, Farber L, Mueller W, Stratz T and Fiebich BL (2005) The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochemical Pharmacology 70 369-380<\/p>\n Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C and Bonavida B (2004) Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance. Oncogene 23 3530-3540<\/p>\n Vega MI, Huerta-Yepaz S, Jazirehi AR, Garban H and Bonavida B (2005) Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. Oncogene 24 8114-8127<\/p>\n Vega MI, Jazirehi AR, Huerta-Yepez S and Bonavida B (2005) Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin’s lymphoma cell line via inhibition of NF-kB activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.\u00a0Journal of Immunology\u00a0175 2174-2183<\/p>\n Vega VL and De Maio A (2003) Geldanamycin treatment ameliorates the response to LPS in murine macrophages by decreasing CD14 surface expression. Molecular Biology of the Cell 14 764-773<\/p>\n Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris EN and Pierangeli SS (2005) Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.\u00a0Arthritis and Rheumatism\u00a052 1545-1554<\/p>\n Vegeler RC, Yip-Schneider MT, Ralstin M, Wu H, Crooks PA, Neelakantan S, Nakshatri H, Sweeney CJ and Schmidt CM (2007) Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.\u00a0Journal of\u00a0Surgical Research 143 169-176<\/p>\n Veiby OP and Read MA (2004) Chemoresistance: impact of Nuclear Factor (NF)-kB inhibition by small interfering RNA: commentary re J. Guo et al., enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kB p65 subunit. Clinical Cancer Research 10 3333-3341<\/p>\n Vejda S, Piwocka K, McKenna SL and Cotter T (2005) GAutocrine secretion of osteopontin results in degradation of IkB in Bcr-Abl-expressing cells. British Journal of Haematology 128 711-721<\/p>\n Veleiro AS, Pecci A, Monteserin MC, Baggio R, Garland MT, Lantos CP and Burton G (2005) 6,19-sulfur-bridged progesterone analogues with antiimmunosuppressive activity. Journal of Medicinal Chemistry 48 5675-5683<\/p>\n Velez-Pardo C and De Rio MJ (2006) Avoidance of Abeta[(25-35)]\/H2O2-induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K-dependent mechanisms: role of NF-kB and p53. Medicinal Chemistry 2 471-479<\/p>\n Velez-Pardo C, Morales AT, Rio MJ and Olivera-Angel M (2007) Endogenously generated hydrogen peroxide induces apoptosis via mitochondrial damage independent of NF-kB and p53 activation in bovine embryos.\u00a0Theriogenology in press<\/p>\n Velez-Pardo C, Ospina GG and Jimenez del Rio M (2002) Abeta[25-35] peptide and iron promote apoptosis in lymphocytes by an oxidative stress mechanism: involvement of H2O2, caspase-3, NF-kB, p53 and c-Jun. Neurotoxicology 23 351-365<\/p>\n Vellaichamy E, Kaur K and Pandey KN (2007) Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A.\u00a0Peptides28 893-899<\/p>\n Vellaichamy E, Khurana ML, Fink J and Pandey KN (2005) Involvement of the NF-kB\/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase\/natriuretic peptide receptor-A. Journal of Biological Chemistry 280 19230-19242<\/p>\n Vellaichamy E, Sommana NK and Pandey KN (2005) Reduced cGMP signaling activates NF-kB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A. Biochemical and Biophysical Research Communications 327 106-111<\/p>\n Vellaichamy E, Zhao D, Somanna N and Pandey KN (2007) Disruption of guanylyl cyclase\/natriuretic peptide receptor-A gene upregulates AT1 receptor signaling in null mutant mice: role in cardiac hypertrophy. Physiological Genomics 31 193-202<\/p>\n Vender JR, Laird MD and Dhadapani KM (2008) Inhibition of NFkB reduces cellular viability in GH3 pituitary adenoma cells. Neurosurgery 62 1122-1127<\/p>\n Vendetti S, Riccomi A, Sacchi A, Gatta L, Pioli C and De Magistris MT (2002) Cyclic adenosine 5′-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4(+) T lymphocytes. Journal of Immunology 169 6231-6235<\/p>\n Vendeville A, Rayne F, Bonhoure A, Bettache N, Montcourrier P and Beaumelle B (2004) HIV-1 Tat enters T-cells using coated pits before translocating from acidified endosomes and eliciting biological responses. Molecular Biology of the Cell 15 2347-2360<\/p>\n Vendrame M, Gemma C, Mesquita DD, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR and Willing AE (2005) Anti-inflammatory effects of human cord blood cells in a rat model of stroke.\u00a0Stem Cells and Development\u00a014 595-604<\/p>\n Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N and Cohen PA (2007) A20\/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.\u00a0Oncogene\u00a026 4656-4667<\/p>\n Venihaki M, Zhao J and Karalis KP (2003) Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. Journal of Neuroimmunology 141 3-9<\/p>\n Venkatachari NJ, Majumder B and Ayyavoo V (2007) Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function.Virology\u00a0358 347-356<\/p>\n Venkatraman A, Ramakrishna B, Shaji R, Nanda Kumar N, Pulimood A and Patra S (2003) Amelioration of dextran sulphate colitis by butyrate; role of heat shock protein 70 and nuclear factor kB. American Journal of Physiology: Gastrointestinal Liver Physiology 285 G177-G184<\/p>\n Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW and Blackwell TS (2000) Exaggerated activation of nuclear factor-kB and altered IkB-beta processing in cystic fibrosis bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 23 396-403<\/p>\n Venkataraman L, Burakoff SJ and Sen R (1995) FK506 inhibits antigen receptor-mediated induction of c-rel\u00a0in B and T lymphoid cells. Journal of Experimental Medicine 181 1091-1099<\/p>\n Venkataraman L, Wang W and Sen R (1996) Differential regulation of c-Rel translocation in activated B and T cells. Journal of Immunology 157 1149-1155<\/p>\n Venkatraman M, Anto RJ, Nair A, Varghese M and Karunagaran D (2005) Biological and chemical inhibitors of NF-kB sensitize SiHa cells to cisplatin-induced apoptosis.\u00a0Molecular Carcinogenesis 44 51-59<\/p>\n Venkatesha RT, Ahamed J, Nuesch C, Zaidi AK and Ali H (2004) Platelet-activating factor-induced chemokine gene expression requires NF-kB activation and Ca2+\/calcinuerin signaling pathways: Inhibition by receptor phosphorylation and beta -arrestin recruitment. Journal of Biological Chemistry 279 44606-44612<\/p>\n Venugopal SK, Devaraj S and Jialal I (2005) Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Current Opinions in Nephrology and Hypertension 14 33-37<\/p>\n Venzi I, Cucinotta M, Caristi S, Mancuso G and Teti D (2007) Transcriptional regulation of IL-8 by Staphylococcus aureus in human conjunctival cells involves activation of AP-1.\u00a0Investigative\u00a0Ophthalmology &\u00a0Vision Science\u00a048 270-276<\/p>\n Verbrugge I, de Vries E, Tait SW, Wissink EH, Walczak H, Verheij M and Borst J (2008) Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway.\u00a0Oncogene\u00a027 574-584<\/p>\n Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W and Vandenabeele P (1998) Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. Journal of Experimental Medicine 188 919-930<\/p>\n Vercammen E, Staal J, Van Den Broeke A, Haegman M, Vereecke L, Schotte P and Beyaert R (2008) Prolonged exposure to IL-1b and IFNg induces necrosis of L929 tumor cells via a p38MAPK\/NF-kB\/NO-dependent mechanism. Oncogene 27 3780-3788<\/p>\n Veres B, Radnai B, Gallyas F, Varbiro G, Berente Z, Osz E and Sumegi B (2004) Regulation of kinase cascades and transcription factors by a poly-(ADP-Ribose) polymerase-1 inhibitor – 4-hydroxyquinazoline – in LPS-induced inflammation in mice. Journal of Pharmacology and Experimental Therapeutics\u00a0310 247-255<\/p>\n Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C adn Bours V (2007) Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.\u00a0Biochemical\u00a0Pharmacology\u00a073 1982-1994<\/p>\n Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G and Goldman M (1999) N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kB inhibition. Journal of Immunology 162 2569-2574<\/p>\n Verhoef K, Sanders RW, Fontaine V, Kitajima S and Berkhout B (1999) Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kB enhancer element into a GABP binding site. Journal of Virology 73 1331-1340<\/p>\n Verkoczy L, Ait-Azzouzene D, Skog P, Martensson A, Lang J, Duong B and Nemazee D (2005) A role for nuclear factor kB\/rel transcription factors in the regulation of the recombinase activator genes. Immunity 322 519-531<\/p>\n Verma A and Mehta K (2007) Tissue transglutaminase-mediated chemoresistance in cancer cells.\u00a0Drug Resistance\u00a0Updates 10 144-151<\/p>\n Verma A and Mehta K (2007) Transglutaminase-mediated activation of nuclear transcription factor-kB in cancer cells: a new therapeutic opportunity.\u00a0CurrentCancer Drug Targets\u00a07\u00a0559-565<\/p>\n Verma IM and Stevenson J (1997) IkB kinase: beginning, not the end. Proceedings of the National Academy of Sciences USA 94 11758-11760<\/p>\n Verma IM and Vogt P (1995) Oncogenes: 20 years later. Genes & Development 9 1289-1301<\/p>\n Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamato S (1995) Rel\/NF-kB\/IkB family: intimate tales of association and disassociation. Genes & Development 9 2723-2735<\/p>\n Verma S, Badiwala MV, Weisel RD, Li SH, Wang CH, Fedak PW, Li RK and Mickle DA (2003) C-reactive protein activates the nuclear factor-kB signal transduction pathway in saphenous vein endothelial cells: Implications for atherosclerosis and restenosis. Journal of Thoracic and Cardiovascular Surgery 126 1886-1891<\/p>\n Verma S, Devaraj S and Jialal I (2006) Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113 2135-2150<\/p>\n Verma UN, Yamamoto Y, Prajapati S and Gaynor RB (2004) Nuclear role of IKKg\/NEMO in NF-kB-dependent gene expression. Journal of Biological Chemistry 279 3509-3515<\/p>\n Vermeulen K, Berneman ZN and Van Bockstaele DR (2003) Cell cycle and apoptosis. Cell Proliferation 36 165-175<\/p>\n Vermeulen L, De Wilde G, Damme PV, Vanden Berghe W and Haegeman G (2003)Transcriptional activation of the NF-kB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO Journal 22 1313-1324<\/p>\n Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W and Haegeman G (2002) Regulation of the transcriptional activity of the nuclear factor-kB p65 subunit. Biochemical Pharmacology 64 963-970<\/p>\n Vermeulen L, Vanden Berghe W and Haegeman G (2006) Regulation of NF-kB transcriptional activity.\u00a0Cancer Treatment and Research\u00a0130\u00a089-102<\/p>\n Verna L, Ganda C and Stemerman MB (2006) In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression.\u00a0Arteriosclerosis, Thrombosis and Vascular Biology\u00a026 1344-1349<\/p>\n Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA and Gamonal J (2004) Levels of cytokine receptor activator of nuclear factor kB ligand in gingival crevicular fluid in untreated chronic periodontitis patients.\u00a0Journal of Periodontology 75 1586-1591<\/p>\n Vernon DO, Garbuzova-Davis S, Desjarlais T, Singh Rasile R, Sanberg PR, Willing AE and Pennypacker KR (2006) Reduced Nuclear Factor kB activation in dentate gyrus after active avoidance training.\u00a0Brain Research 1104 39-44<\/p>\n Verrax J, Cadrobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper HS and Buc Calderon P (2003) The association of vitamins C and K(3) kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. European Journal of Medicinal Chemistry 38 451-457<\/p>\n Verrax J, Cadrobbi J, Marques C, Taper H, Habraken Y, Piette J and Calderon PB (2004) Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death. Apoptosis 9 223-233<\/p>\n Verrecchia F, Tacheau C, Wagner EF and Mauviel A (2003) A central role for the Jun-N-terminal kinase pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven Smad3\/4-specific gene expression. Journal of Biological Chemistry 278 1585-1593<\/p>\n Verrecchia F, Wagner EF and Mauviel A (2002) Distinct involvement of the Jun-N-terminal kinase and NF-kB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Reports 3 1069-1074<\/p>\n Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM and Beyaert R (2008) Expression of the NF-kB inhibitor ABIN-3 in response to TNF and Toll-like receptor 4 stimulation is itself regulated by NF-kB. Journal of Cellular and Molecular Medicine 12 316-329<\/p>\n Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, and Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-kB: variations on a common theme. Cellular and Molecular Life Sciences in press<\/p>\n Verweij Cl, Geerts M and Aarden LA (1991) Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. Journal of Biological Chemistry 266 14179-14182<\/p>\n Verzijl D, Fitzsimons CP, Van Dijk M, Stewart JP, Timmerman H, Smit MJ and Leurs R (2004) Differential activation of murine herpesvirus 68- and Kaposi’s sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. Journal of Virology 78 3343-3351<\/p>\n Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Salvatore F, Berruti V, Gandolfo MT, Garibotto G and Deferrari G (2003) Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. Journal of the American Society of Nephrology 15 S85-S87<\/p>\n Vesely DL, Hoffman B and Liebermann DA (2006) Phosphatidylinositol 3-kinase\/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.\u00a0Oncogene\u00a0in press<\/p>\n Vestergaard C, Johansen C, Otkjaer K, Deleuran M and Iversen L (2005) Tumor necrosis factor-a-induced CTACK\/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kB. Cytokine 29 49-55<\/p>\n Vianole G, Reale M, Amerio P, Steanachi M, Di Luzio S and Muraro R (2008) Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production. British Journal of Dermatology in press<\/p>\n Viatour P, Bentires-Alj M, Chariot A, Deregowski V, De Leval L, Merville MP and Bours V (2003) NF-kB2\/p100 induces Bcl-2 expression. Leukemia 17 1349-1356<\/p>\n Viatour P, Dejardin E, Warnier M, Lair F, Claudio E, Bureau F, Marine JC, Merville MP, Maurer U, Green D, Piette J, Siebenlist U, Bours V and Chariot A (2004) GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular Cell 16 35-45<\/p>\n Viatour P, Legrand-Poels S, Van Lint C, Warnier M, Merville MP, Gielen J, Bours V and Chariot A (2003) Cytoplasmic IkBa increases NF-kB-independent transcription through binding to HDAC1 and HDAC3. Journal of Biological Chemistry 278 46541-46548<\/p>\n Viatour P, Merville MP, Bours V and Chariot A (2004) Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity. Cell Cycle 3 1498-1501<\/p>\n Viatour P, Merville MP, Bours V and Chariot A (2005) Phosphorylation of NF-kB and IkB proteins: implications in cancer and inflammation. Trends in Biochemical Sciences 30 43-52<\/p>\n Vicente AM, Guillen MI and Alcaraz MJ (2001) Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. British Journal Pharmacology 133 920-926<\/p>\n Vickers TA, Griffith MC, Ramasamy K, Risen LM and Freier SM (1995) Inhibition of NF-kB specific transcriptional activation by PNA strand invasion. Nucleic Acids Research 23 3003-3008<\/p>\n Vickers TA, Zhang H, Graham MJ, Lemonidis KM Zhao C and Dean NM (2006) Modification of MyD88 mRNA splicing and inhibition of IL-1b signaling in cell culture and in mice with a 2′-O-methoxyethyl-modified Ooligonucleotide. Journal of Immunology\u00a0176\u00a03652-3661<\/p>\n Victor FC, Gottlieb AB and Menter A (2003) Changing paradigms in dermatology: tumor necrosis factor alpha (tnf-alpha) blockade in psoriasis and psoriatic arthritis. Clinical Dermatology 21 392-397<\/p>\n Victor VM and De la Fuente M (2002) N-acetylcysteine improves in vitro the function of macrophages from mice with endotoxin-induced oxidative stress. Free Radical Research 36 33-45<\/p>\n Victor VM and De la Fuente M (2003) Immune cells redox state from mice with endotoxin-induced oxidative stress. Involvement of NF-kB. Free Radical Research 37 19-27<\/p>\n Victor VM, Rocha M and De La Fuente M (2004) Immune cells: free radicals and antioxidants in sepsis. International Immunopharmacology 4 327-347<\/p>\n Victor VM, Rocha M and De la Fuente M (2003) N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radical Research 37 919-929<\/p>\n Vicotr VM, Rocha M, Esplugues JV and De la Fuente M (2005) Role of free radicals in sepsis: antioxidant therapy.\u00a0Curr Pharm Des\u00a011 3141-3158<\/p>\n Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG and Okamoto T (2006) Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkB kinase inhibitor.\u00a0Antimicrobioal\u00a0Agents and Chemotherapy\u00a050 547-555<\/p>\n Vidaeff AC, Ramin SM, Gilstrap 3rd LC, Bishop KD and Alcorn JL (2007) Impact of progesterone on cytokine-stimulated nuclear factor-kB signaling in HeLa cells.Journal of\u00a0Maternal- Fetal Neonatal Medicine\u00a02007 Jan;20(1):23-8<\/p>\n Vidal C, Gomez-Hernandez A, Sanchez-Galan E, Gonzalez A, Ortega L, Gomez-Gerique JA, Tunon J and Egido J (2006) Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. Journal of Pharmacology and Experimental Therapeutics 320 108-116<\/p>\n Vidal MA, Astroza A, Matus CE, Ehrenfeld P, Pavicic F, Sanchez T, Salem C, Figueroa J, Concha M, Gonzalez CB and Figueroa CD (2005) Kinin b2 receptor-coupled signal transduction in human cultured keratinocytes. Journal of Investigative Dermatology 124 178-186<\/p>\n Vidal S, Khush RS, Leulier F, Tzou P, Nakamura M and Lemaitre B (2001) Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel\/NF-kB-dependent innate immune responses. Genes & Development 15 1900-1912<\/p>\n Videla LA, Fernandez V, Tapia G and Varela P (2003) Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 16 103-111<\/p>\n Videla LA, Tapia G, Varela P, Cornejo P, Guerrero J, Israel Y and Fernandez V (2004) Effects of acute gamma-hexachlorocyclohexane intoxication in relation to the redox regulation of nuclear factor-kB, cytokine gene expression, and liver injury in the rat. Antioxidants and Redox Signaling 6 471-480<\/p>\n Viedt C, Dechend R, Fei J, Hansch GM, Kreuzer J and Orth SR (2002) MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kB and activating protein-1. Journal of the American Society of Nephrology 13 1534-1547<\/p>\n Viedt C, Shen W, Fei J, Kamimura M, Hansch GM, Katus HA and Kreuzer J (2003) HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9. Basic Research in Cardiology 98 353-361<\/p>\n Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W and Kreuzer J (2002) Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kB and activator protein-1. Arteriosclerosis, Thrombosis, and Vascular Biology 22 914-920<\/p>\n Vielma SA, Krings G and Lopes-Virella MF (2003) Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kB. Circulation Research 92 1130-1137<\/p>\n Viemann D, Goebeler M, Schmid S, Klimmek K, Sorg C, Ludwig S and Roth J (2004) Transcriptional profiling of IKK2\/NF-kB- and p38 MAP kinase-dependent gene expression in TNF-a-stimulated primary human endothelial cells. Blood 103 3365-3373<\/p>\n Viemann D, Schmidt M, Tenbrock K, Schmid S, Muller V, Klimmek K, Ludwig S, Roth J and Goebler M (2007) The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kB and hypoxia-inducible factor-1a. Journal of\u00a0Immunology\u00a0178\u00a03198-3207<\/p>\n Vier J, Gerhard M, Wagner H and Hacker G (2004) Enhancement of death-receptor induced caspase-8-activation in the death-inducing signalling complex by uncoupling of oxidative phosphorylation. Molecular Immunology 40 661-670<\/p>\n Vierstraete E, Verleyen P, Baggerman G, D’Hertog W, Van Den Bergh G, Arckens L, De Loof A and Schoofs L (2004) A proteomic approach for the analysis of instantly released wound and immune proteins in Drosophila melanogaster hemolymph. Proceedings of the National Academy of Sciences USA 101 470-475<\/p>\n Vig E, Green M, Liu Y, Donner DB, Mukaida N, Goebl MG and Harrington MA (1999) Modulation of tumor necrosis factor and interleukin-1-dependent NF-kB activity by mPLK\/IRAK. Journal of Biological Chemistry 274 13077-13084<\/p>\n Vig-Varga E, Benson EA, Limbil TL, Allison Bm, Goebl MG and Harrington MA (2006) alpha-lipoic acid modulates ovarian surface epithelial cell growth.\u00a0Gynecology and Oncology\u00a0103 45-52<\/p>\n Vignola AM, Chiappara G, Siena L, Bruno A, Gagliardo R, Merendino AM, Polla BS, Arrigo AP, Bonsignore G, Bousquet J and Chanez P (2001) Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. Journal of Allergy and Clinical Immunology 108 738-746<\/p>\n Vigorito E, Gambardella L, Colucci F, McAdam S and Turner M (2005) Vav proteins regulate peripheral B cell survival. Blood 106 2391-2398<\/p>\n Vila-Del Sol V, Diaz-Munoz MD and Fresno M (2006) Requirement of tumor necrosis factor alpha and nuclear factor-kB in the induction by IFN-g of inducible nitric oxide synthase (iNOS) in macrophages.\u00a0Journal of\u00a0Leukocyte Biology in press<\/p>\n Vila-Del Sol V and Fresno M (2005) Involvement of TNF and NF-kB in the transcriptional control of cyclooxygenase-2 expression by IFN-gamma in macrophages. Journal of Immunology 174 2825-2833<\/p>\n Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V and Ibanez CF (2006) Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle.\u00a0EMBO Journal 25 1219-1230<\/p>\n Vilela RM, Lands LC, Meehan B and Kubow S (2006) Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.International Immunopharmacology\u00a06 1651-1664<\/p>\n Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L and Aifantis I (2007) Targeting the NF-kB signaling pathway in Notch1-induced T-cell leukemia.Nature Medicine 13 70-77<\/p>\n Villalba M and Altman A (2002) Protein Kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemias. Current Cancer Drug Targets 2 125-137<\/p>\n <\/strong>Villalba M, Bi K, Hu J, Altman Y, Bushway P, Reits E, Neefjes J, Baier G, Abraham RT and Altman A (2002) Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. Journal of Cell Biology 157 253-263<\/p>\n Villalba M, Bushway P and Altman A (2001) Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD. Journal of Immunology 166 5955-5963<\/p>\n Villalona-Calero M, Schaaf L, Phillips G, Otterson G, Panico K, Duan W, Kleiber B, Shah M, Yong D, Wu WH and Kuhn J (2007) Thalidomide and celecoxib as potential modulators of irinotecan’s activity in cancer patients.\u00a0Cancer Chemotherapy and\u00a0Pharmacology 59 23-33<\/p>\n Villar J, Celay J, Alonso MM, Rotinen M, de Miguel C, Migliaccio M and Encio I (2007) Transcriptional regulation of the human type 8 17beta-hydroxysteroid dehydrogenase gene by C\/EBPbeta.\u00a0Journal of\u00a0Steroid Biochemistry and\u00a0MolecularBiology 105 131-139<\/p>\n Villunger A, Ghaffari-Tabrizi N, Tinhofer I, Krumbock N, Bauer B, Schneider T, Kasibhatla S, Greil R, Baier-Bitterlich G, Uberall F, Green DR and Baier G (1999) Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells. European Journal of Immunology 29 3549-3561<\/p>\n Vimalachandran D, Greenhalf W, Thompson C, Luttges J, Prime W, Campbell F, Dodson A, Watson R, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos J and Costello E (2005) High nuclear S100A6 (calcyclin) is significantly associated with poor survival in pancreatic cancer patients.\u00a0Cancer Research 65 3218-3225<\/p>\n Vina J, Borras C, Gambini J, Sastre J, Pallardo FV (2005) Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Letters 579 2541-2545<\/p>\n Vina J, Sastre J, Pallardo FV, Gambini J and Borras C (2008) Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem\u00a0389 273-277<\/p>\n Vinayagamoorthi R, Koner BC, Kavitha S, Nandakumar DN, Padma Priya P and Goswami K (2005) Potentiation of humoral immune response and activation of NF-kB pathway in lymphocytes in experimentally induced hyperthyroid rats.\u00a0Cellular\u00a0Immunology 238 56-60<\/p>\n Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, Yeoh G, Brink R, Vaux DL and Silke J (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFa. Journal of Cell Biology in press<\/p>\n Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL and Silke J (2007) IAP antagonists target cIAP1 to induce TNFa-dependent apoptosis. Cell 131 682-693<\/p>\n Vincenti MP, Burrell TA and Taffet SM (1992) Regulation of NF-kB activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester. Journal of Cellular Physiology 150 204-213<\/p>\n Vincinguerra M, Hasler U, Mordasini D, Roussel M, Capovilla M, Ogier-Denis E, Vandewalle A, Martin PY and Feraille E (2005) Cytokines and sodium induce protein kinase A-dependent cell-surface Na,K-ATPase recruitment via dissociation of NF-kB\/IkB\/protein kinase A catalytic subunit complex in collecting duct principal cells. Journal of the American Society of Nephrology 16 2576-2585<\/p>\n Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F and Foti M (2008) PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kBp65\/mTOR-dependent mechanism. Gastroenterology 134 268-280<\/p>\n Vines A, Cahoon S, Goldberg I, Saxena U and Pillaarisetti S (2006) Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-a- and interleukin-1b-induced inflammatory gene expression. Journlal of Biological Chemistry 281 16985-16990<\/p>\n Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G and de Kleijn DP (2002) In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106 1985-1990<\/p>\n Vincenti MP, Coon CI and Brinckerhoff CE (1998) Nuclear factor kB\/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1b-stimulated synovial fibroblasts. Arthritis and Rheumatism 41 1987-1994<\/p>\n Vinolo E, Sebban H, Chaffotte A, Israel A, Courtois G, Veron M and Agou F (2006) A point mutation in NEMO associated with EDA-ID pathology results in destabilisation of the oligomer and reduces LPS- and TNF-mediated NF-kB activation.\u00a0Journal of\u00a0Biological\u00a0Chemistry 281 6334-6348<\/p>\n Virag L (2005) Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharmacology\u00a0Research\u00a052 83-92<\/p>\n Virag L (2005) Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Current Vascular Pharmacology 3 209-214<\/p>\n Virlos I, Mazzon E, Serraino I, Di Paola R, Genovese T, Britti D, Thiemerman C, Siriwardena A, Cuzzocrea S (2003) Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 20 544-550<\/p>\n Virlos I, Mazzon E, Serraino I, Genovese T, Di Paola R, Thiemerman C, Siriwardena A and Cuzzocrea S (2004) Calpain I inhibitor ameliorates the indices of disease\u00a0severity in a murine model of cerulein-induced acute pancreatitis. Intensive Care Med 30 1645-1651<\/p>\n Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M and Fusco A (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkB p65 protein expression. Oncogene 15 1987-1994<\/p>\n Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, Zeita M, Kaufmann SH, Schmidt-Ullrich R and Steinhoff U (2006) Proteasome-mediated degradation of IkBa and processing of p105 in Crohn disease and ulcerative colitis.\u00a0Journal ofClinical\u00a0Investigation 116 3195-3203<\/p>\n Visentin S, Renzi M and Levi G (2001) Altered outward-rectifying K(+) current reveals microglial activation induced by HIV-1 Tat protein. Glia 33 181-190<\/p>\n Visigalli R, Bussolati O, Sala R, Barilli A, Rotoli BM, Parolari A, Alamanni F, Gazzola GC and Dall’Asta V (2004) The stimulation of arginine transport by TNFa in human endothelial cells depends on NF-kB activation. Biochimica et Biophysica Acta 1664 45-52<\/p>\n Visintin M, Melchionna T, Cannistraci I and Cattaneo A (2008) In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an “undruggable” class of disease targets. Journal of Biotechnology135 1-15<\/p>\n Visvanathan KV and Goodbourn S (1989) Double-stranded RNA activates binding of NF-kB to an inducible element in human beta-interferon promoter. EMBO Journal 8 1129-1138<\/p>\n Visvanathan M, Breit M, Pfeifer B, Baumgartner C, Modre-Osprian R, and Tilg B (2007) Systematic analysis of signaling pathways using an integrative environment.\u00a0Methods\u00a0of\u00a0Information in\u00a0Medicine\u00a046 386-391<\/p>\n Viswanathan M, Yu M, Mendoza L and Yunis JJ (1996) Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter. Gene 170 271-276<\/p>\n Vital AL, Goncalo M, Cruz MT, Figueiredo A, Duarte CB and Celeste Lopes M (2003) Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line. Mediators of Inflammation 12 71-78<\/p>\n Viterbo D, Bluth MH, Lin YY, Mueller CM, Wadgaonkar R and Zenilman ME (2008) Pancreatitis-associated protein 2 modulates inflammatory responses in macrophages. Journal of Immunology 181 1948-1958<\/p>\n Viterbo D, Bluth MH, Mueller CM and Zenilman ME (2008) Mutational characterization of pancreatitis-associated protein 2 domains involved in mediating cytokine secretion in macrophages and the NF-kB pathway. Journal of Immunology 181 1948-1958<\/p>\n Vitiello M, D’Isanto M, Galdiero M, Raieta K, Tortora A, Rotondo P, Peluso L and Galdiero M (2004) Interleukin-8 production by THP-1 cells stimulated by Salmonella enterica serovar Typhimurium porins is mediated by AP-1, NF-kB and MAPK pathways. Cytokine 27 15-24<\/p>\n Vitovski S, Phillips JS, Sayers J and Croucher PI (2007) Investigating the interaction between osteoprotegerin and receptor activator of NF-kB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways. Journal of Biological Chemistry 282 31601-31609<\/p>\n Vitseva OL, Tanriverdi K, Tchkonia TT, Kirkland JL, McDOnnell ME, APovian CM, Freedman J and Gokce N (2008) Inducible Toll-like receptor and NF-kB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) in press<\/p>\n Vitturo E, Farke C, Meyer HH and Albrecht C (2006) Identification, sequence analysis and mRNA tissue distribution of the bovine sterol transporters ABCG5 and ABCG8.\u00a0Journal of\u00a0Dairy Science\u00a089 553-561<\/p>\n Vlach J and Pitha PM (1992) Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kB binding proteins. Virology 187 63-72<\/p>\n Vlach J and Pitha PM (1992) Herpes simplex virus type 1-mediated induction of human immunodeficiency viurs type 1 provirus correlates with binding of nuclear proteins to the NF-kB enahncer and leader sequence. Journal of Virology 66 3616-3623<\/p>\n Vlach J, Garcia A, Jacqu\u00e9 J-M, Rodriguez MS, Michelson S and Virelizier J-L (1995) Induction of Sp1 phosphorylation and NF-kB-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 208 753-761<\/p>\n Vlaeminck-Guillem V, Laudet V and Duterque-Coquillaud M (2003) Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis [Article in French]. Med Sci (Paris) 19 1121-1127<\/p>\n Vlahopoulos S, Boldogh I, Casola A and Brasier AR (1999) Nuclear factor-kB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94 1878-1889<\/p>\n Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L and Anderson GP (2005) Differential protease, innate immunity and NFkB induction profiles during lung inflammation induced by sub-chronic cigarette smoke exposure in mice. American\u00a0Journal of\u00a0Physiology:\u00a0Lung Cell\u00a0andMolecular\u00a0Physiology 290 L931-L945<\/p>\n Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F, Moldawer LL, Ramsay Camp E and MacKay SL (2004) Inhibition of NF-kB augments sensitivity to 5-Fluorouracil\/Folinic acid in colon cancer(1). Journal of Surgical Research 120 178-188<\/p>\n Voboril R, Voborliova J, Rychterova V, Jrasek T and Dvorak J (2008) Dissociated invasively growing cancer cells with NF-kB\/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data. Clinical and Experimental Metastasis in press<\/p>\n Voboril R, Weberova J and Dvorak J (2005) The molecular screening of the stool for the colorectal carcinoma [Article in Czech].\u00a0Rozhl Chir\u00a084 281-285<\/p>\n Voboril R and Weberova-Voborilova J (2006)\u00a0Constitutive NF-kB activity in colorectal cancer cells: impact on radiation-induced NF-kB activity, radiosensitivity, and apoptosis.\u00a0Neoplasma\u00a053\u00a0518-523<\/p>\n Voboril R and Weberova-Voborilova J (2007)\u00a0Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kB.Neoplasma\u00a054\u00a0495-502<\/p>\n Voboril R, Weberova-Voborilova J, Rychterova V, Ambrus M, Horak L and Fanta J (2007) NF-kB, colorectal carcinoma and radiotherapy: results of a clinical and experimental study [Article in Czech].\u00a0Rozhledy\u00a0v\u00a0Chirurgii\u00a086 268-272<\/p>\n Vockerodt\u00a0M, Haier B, Buttgereit P, Tesch H and Kube D (2001) The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt’s lymphoma cells but not in Hodgkin’s cells involving the p38\/SAPK2 pathway. Virology 280 183-198<\/p>\n Vockerodt M, Pinkert D, Smola-Hess S, Michels A, Ransohoff RM, Tesch H and Kube D (2004) The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation. Internatinal Journal of Cancer 114 598-605<\/p>\n Vockerodt M, Tesch H and Kube D (2002) Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkB pathway. Genes & Immunity 2\u00a0433-441<\/p>\n Vodanovic-Jankovic S, Hari P, Jacobs P, Komorowski R and Drobyski WR (2005) NF-kB as a target for the prevention of graft versus host disease: comparative efficacy of bortezomib and PS-1145. Blood\u00a0107 827-834<\/p>\n Voelter-Mahlknecht S and Mahlknecht U (2006) Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1.\u00a0International\u00a0Journal of Molcular Medicine\u00a017 59-67<\/p>\n Vogel CF, Sciullo E, Li W, Wong P, Lazennec G and Matsumura F (2007) RELB, a new partner of aryl hydrocarbon receptor-medicated transcription. Molecular Endocrinology 21 2941-2955<\/p>\n Vogel CF, Sciullo E and Matsumura F (2007) Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Vogel CF, Zhao Y, Wong P, Young NF and Matsumura F (2003) The use of c-src knockout mice for the identification of the main toxic signaling pathway of TCDD to Induce wasting syndrome. Journal of Biochemical and Molecular Toxicology 17 305-315<\/p>\n Vogel G (1998) Fly development genes lead to immune find. Science 281 1942-1944<\/p>\n Vogel NL, Boeke M and Ashburner BP (2006)\u00a0Spermidine\/Spermine N(1)-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kB and cooperates with CBP and P\/CAF to enhance NF-kB-dependent transcription.\u00a0Biochimica etBiophysica\u00a0Acta\u00a01759 470-477<\/p>\n Vogel S, Orrington-Myers J, Broman M and Malik AB (2006) De novo ICAM-1 synthesis in the mouse lung: model of assessment of protein expression in lungs.American\u00a0Journal\u00a0of\u00a0Physiology:\u00a0Lung Cell\u00a0and\u00a0Molecular\u00a0Physiology 291 L496-L501<\/p>\n Vogel SN, Johnson D, Perera PY, Medvedev A, Lariviere L, Qureshi ST and Malo D (1999) Functional characterization of the effect of the C3H\/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. Journal of Immunology 162 5666-5670<\/p>\n Vogel U, Nexo BA, Tjonneland A, Wallin H, Hertel O and Raaschou-Nielsen O (2006) ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutation Research\u00a0593 88-96<\/p>\n Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll, Sorg C and Roth J (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.Nature\u00a0Medicine 13 1042-1049<\/p>\n Vogt PK (2001) Jun, the oncoprotein. Oncogene 20 2365-2377<\/p>\n Voisard R, Huber N, Baur R, Susa M, Ickrath O, Both A, Koenig W and Hombach V (2001) Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells. BMC Molecular Biology 2\u00a0 7<\/p>\n Volanti C, Gloire G, Vanderplasschen A, Jacobs N, Habraken Y and Piette J (2004) Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23 8649-8658<\/p>\n Volanti C, Hendrickx N, Van Lint J, Matroule JY, Agostinis P and Piette J (2005) Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumourcells after photodynamic therapy. Oncogene 24 2981-2991<\/p>\n Voleti B and Agrawal A (2005) Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kB on the proximal promoter.\u00a0Journal of Immunology\u00a0175 3386-3390<\/p>\n Volger OL, Fledderus JO, Kisters N, Fontijn RD, Moerland PD, Kuiper J, van Berkel TJ, Bijnens AP, Daemen MJ, Pannekoek H and Horrevoets AJ (2007) Distinctive expression of chemokines and transforming growth factor-b Signaling in human arterial endothelium during atherosclerosis.\u00a0American Journal of Pathology\u00a0171 326-337<\/p>\n Volk DE, Yang\u00a0X, Fennewald SM, King DJ, Bassett SE, Venkitachalam S, Herzog N, Luxon BA, Gorenstein DG (2002) Solution structure and design of dithiophosphate backbone aptamers targeting transcription factor NF-kB. Bioorganic Chemistry 30 396-419<\/p>\n Volkoff AN, Rocher J, d’Alencon E, Bouton M, Landais I, Quesada-Moraga E, Vey A, Fournier P, Mita K and Devauchelle G (2003) Characterization and transcriptional profiles of three Spodoptera frugiperda genes encoding cysteine-rich peptides. A new class of defensin-like genes from lepidopteran insects? Gene 319 43-53<\/p>\n Voll RE, Mikulowska A, Kalden JR and Holmdahl R (1999) Amelioration of type II collagen induced arthritis in rats by treatment with sodium diethyldithiocarbamate. Journal of Rheumatology 26 1352-1358<\/p>\n Vollgraf U, Wegner M and Richter-Landsberg C (1999) Activation of AP-1 and nuclear factor-kB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. Journal of Neurochemistry 73 2501-2509<\/p>\n Volp K, Brezniceanu ML, Bosser S, Brabletz T, Kirchner T, Gottel D, Joos S and Zornig M (2006) Increased expression of High Mobility Group Box 1 (HMGB1) is associated with an elevated level of the anti- apoptotic c-IAP2 protein in human colon carcinomas. Gut 55 234-242<\/p>\n Volpini RA, balbi AP, Costa RS and Coimbra TM (2006) Increased expression of p38 mitogen- activated protein kinase is related to the acute renal lesions induced by gentamicin. Volpini RA, Costa RS, da Silva CG and Coimbra TM (2004) Inhibition of nuclear factor-kB activation attenuates tubulointerstitial nephritis induced by gentamicin. Nephron Physiology 98 97-106<\/p>\n von Albertini M, Ferran C, Brostjan C, Bach FH and Goodman DJ (1998)\u00a0Membrane-associated lymphotoxin on natural killer cells activates endothelial cells via an NF-kB-dependent pathway. Transplantation 66 1211-1219<\/p>\n von Bernuth H, Puel A, Ku CL, Yang K, Bustamante J, Chang HH, Picard C and Casonova JL (2005) Septicemia without sepsis: inherited disorders of nuclear factor-kB-mediated inflammation.\u00a0Clinical Infectious Disease\u00a041 S436-S439<\/p>\n von Beust BR, Johansen P, Smith KA, Bot A, Storni T and Kundig TM (2005) Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. European Journal of Immunology 35 1869-1876<\/p>\n von Bismarck P, Klemm K, Wistadt CF, Winoto-Morbach S, Uhlig U, Schutze S, Uhlig S, Lachmann B and Krause MF (2007) Surfactant “fortification” by topical inhibition of nuclear factor-kB activity in a newborn piglet lavage model.Critical\u00a0Care Medicine\u00a035 2309-2318<\/p>\n von Brandenstein MG, Ngum Abety A, Depping R, Roth T, Koehler M, Dienes HP and Fries JW (2008) A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. Biochimica et Biophysica Acta 1783 1613-1622<\/p>\n Von Bubnoff D, Novak N, Kraft S and Bieber T (2003) The central role of FcepsilonRI in allergy. Clinical and Experimental Dermatology 28 184-187<\/p>\n von Bulow GU, Russell H, Copeland NG, Gilbert DJ, Jenkins NA and Bram RJ (2000) Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mammalian Genome 11 628-632<\/p>\n von Bulow V, Dubben S, Engelhardt G, Hebel S, Plumakers B, Heine H, Rink L and Haase H (2007) Zinc-dependent suppression of TNF-a production is mediated by protein kinase A-induced inhibition of Raf-1, IkB kinase beta, and NF-kB.Journal of Immunology 179 4180-4186<\/p>\n von Gagern G, Zimmermann T, Albrecht S, Bachmann L, Zwipp H and Saeger HD (1999) [Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study]. Med Klin 94 Suppl 3 62-65<\/p>\n von Haehling S, Genth-Zotz S, Anker S and Volk H (2002) Cachexia: a therapeutic approach beyond cytokine antagonism. International Journal of Cardiology 85 173-183<\/p>\n von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK and Swisher SG (2007) The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kB and Akt activation.\u00a0Clinical\u00a0Cancer Research 13 6032-6039ical\u00a0Cancer Research 13 6032-6039ical\u00a0Cancer Research 13 6032-6039<\/p>\n von Knethen A, Callsen D and Brune B (1999) NF-kB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Molecular Biology of the Cell 10 361-372<\/p>\n von Knethen A, Callsen D and Brune B (1999) Superoxide attenuates macrophage apoptosis by NF-kB and AP-1 activation that promotes cyclooxygenase-2 expression. Journal of Immunology 163 2858-2866<\/p>\n von Knethen A, Soller M, Tzieply N, Wiegert A, Johann AM, Jennewein C, Kohl R and Brune B (2007) PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes\/macrophages.\u00a0Journal of\u00a0Cell Biology\u00a0176 681-694<\/p>\n von Leoprechting A, van der Bruggen P, Pahl HL, Aruffo A and Simon JC (1999) Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Research 59 1287-1294<\/p>\n von Metzler I, Krebbel H, Hecht M, Manz RA, Fleissner C, Mieth M, Kaiser M, Jakob C, Sterz J, Kleeberg L, Heider U and Sezer O (2007) Bortezomib inhibits human osteoclastogenesis.\u00a0Leukemia\u00a021 2025-2034<\/p>\n Von Wnuck Lipinski K, Keul P, Ferri N, Lucke S, Heusch G, Fischer JW and Levkau B (2006) Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen.\u00a0Circulation\u00a0Research 98 1490-1497<\/p>\n Vona-Davis L, Yu A, Magabo K, Evans T, Jackson B, Riggs D and McFadden D (2004) Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis. Journal of the American College of Surgeons 199 87-95<\/p>\n Vona-Davis L, Zhu X, Yu AK and McFadden DW (2003) Modulation of interleukin-6 in cardiac myoblasts during endotoxemia. Journal of Surgical Research 112 91-96<\/p>\n Voon DC, Subrata LS, Karimi M, Ulgiati D and Abraham LJ (2004) TNF and phorbol esters induce lymphotoxin-beta expression through distinct pathways involving Ets and NF-kB family members. Journal of Immunology 172 4332-4341<\/p>\n Voorhees PM, Dees EC, O’Neil B and Orlowski RZ (2003) The proteasome as a target for cancer therapy. Clincal Cancer Research 9 6316-6325<\/p>\n Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, Lukasek K, Michelsen KS, Wada A, Hirayama T, Arditi M and Abreu MT (2004) beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. Journal of Immunology 173 5398-5405<\/p>\n Voronov I, Li K, Tenenbaum HC and Manolson MF (2008) Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-kB. Biochemical Pharmacology 75 2034-2044<\/p>\n Vos IH, Govers R, Grone HJ, Kleij L, Schurink M, De Weger RA, Goldschmeding R and Rabelink TJ (2000) NFkB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB Journal 14 815-822<\/p>\n Vos TA, Goor H, Tuyt L, Jager-Krikken A, Leuvenink R, Kuipers F, Jansen PL and Moshage H (1999) Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 29 421-426<\/p>\n Vosse E, Hoeve MA and Ottenhoff TH (2004) Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infectious Disease 4 739-749<\/p>\n Vosters O, Beuneu C, Goldman M and Verhasselt V (2008)\u00a0N-acetylcysteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells. Pancreas 36 363-368<\/p>\n Vosters O, Beuneu C, Nagy N, Movahedi B, Aksoy E, Salmon I, Pipeleers D, Goldman M and Verhasselt V (2004) CD40 expression on human pancreatic duct cells: role in nuclear factor-kB activation and production of pro-inflammatory cytokines. Diabetologia 47 660-668<\/p>\n Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A and Motte J (2004) Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiology and Disease 17 385-402<\/p>\n Vroling AB, Jonker MJ, Luiten S, Breit TM, Fokkens WJ and van Drunen CM (2008) Primary Nasal epithelium exposed to house dust mite extract shows activated expression in allergics.\u00a0American Journal of Respiratory Cell and Molecular Biology\u00a038 293-299<\/p>\n Vuillard L, Nicholson J and Hay RT (1999) A complex containing betaTrCP recruits Cdc34 to catalyze ubiquitination\u00a0of IkBa. FEBS Letters 455 311-314<\/p>\n Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC and Prabhu KS (2007) The antiinflammatory effects of selenium are mediated through 15-deoxy-u 12,14-prostaglandin J2 in macrophages.\u00a0Journal ofBiological Chemistry 282 17964-17973<\/p>\n Vuolteenaho K, Kujala P, Moilanen T and Moilanen E (2005) Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage.\u00a0Scandinavian\u00a0Journal of Rheumatology\u00a034 475-479<\/p>\n Vuori KA, Nordlund E, Kallio J, Salakoski T and Nikinimaa M (2008) Tissue-specific expression of aryl hydrocarbon receptor and putative developmental regulatory modules in Baltic salmon yolk-sac fry. Aquatic Toxicology 87 19-27<\/p>\n Vykhovanets EV, Shukla S, Maclennan GT, Resnick MI, Carlsen H, Blomhoff R and Gupta S (2007) Molecular imaging of NF-kB in prostate tissue after systemic administration of IL-1beta. Prostate 68 34-41<\/p>\n Vuolteenaho K, Moilanen T, Jalonen Y, Lahti A, Nieminen G, Beuningen HM, Kraan PM and Moilanen E (2005) TGFbeta inhibits IL-1 -induced iNOS expression and NO production in immortalized chondrocytes. Inflammation Research 54 420-427<\/p>\n","protected":false},"excerpt":{"rendered":" Vaayssier M, Favatier F, Pinot F, Bachelet M and Polla BS (1998) Tobacco smoke induces coordinate activation of NSF and inhibition of NFkB in human monocytes: effects on TNFa release. Biochemical and Biophysical Research Communications 252 249-256 Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M, Frati L, Gulino A […]<\/p>\n","protected":false},"author":4258,"featured_media":0,"parent":201,"menu_order":22,"comment_status":"closed","ping_status":"open","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/276"}],"collection":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/users\/4258"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/comments?post=276"}],"version-history":[{"count":3,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/276\/revisions"}],"predecessor-version":[{"id":279,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/276\/revisions\/279"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/201"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/media?parent=276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nEuropean\u00a0Journal of Immunology 36 2223-2234<\/p>\n
\n
\n<\/strong>Vanden Berghe W, De Bosscher K, Boone E, Plaisance S and Haegeman G (1999) The nuclear factor-kB engages CBP\/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. Journal of Biological Chemistry 274 32091-32098<\/p>\n
\nJournal of Bone and Mineral Research 19 1651-1660<\/p>\n
\nBiochemical and\u00a0Biophysical\u00a0Research\u00a0Communications 363 722-726<\/p>\n
\nBrazilian\u00a0Journal of Medical and Biological Research\u00a039 817-823<\/p>\n